Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00333099Phase 4Completed

INEC Study: Immuno-modulating Enteral Nutrition in Cancer

Role: collaborator

NCT06080399Completed

Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease

Role: collaborator

NCT04179695Not ApplicableRecruiting

Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care

Role: collaborator

NCT03976180Not ApplicableRecruiting

High-flow Oxygen for Vaso-occlusive Pain Crisis

Role: collaborator

NCT03213379Not ApplicableUnknown

Assessment of Actigraphy Procedures on the Initiation of an Apomorphine Treatment Delivered Through a Pump to Patients With Parkinson's Disease

Role: lead

All 5 trials loaded